Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Qiagen; GeneLink; Malaysian Genomics Resource Centre Berhad

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen said this week that it has created a sponsored professorship — the Qiagen Initiative Foundation Professorship — at the University of Science and Technology of China. The sponsorship agreement has a term of 10 years and supports a full-time professor position in the life sciences field.


GeneLink, a seller of consumer genetics services, this week said that its 2009 revenues increased 34 percent to $8.6 million from $6.4 million in 2008. Its fourth-quarter sales increased 10 percent year over year to $2.3 million from $2.1 million, and its Q4 net loss dropped to $552,093 from $783,794, the Orlando, Fla.-based firm said.


The Malaysian Genomics Resource Centre Berhad has launched its Human Genome Bioinformatics service, which costs $4,000, the center said this week. The service provides customers with "end-to-end bioinformatics analysis" of DNA sequencing data, it said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more